VYNE Therapeutics Inc. - VYNE
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Aug 14, 2026 | SCHEDULE 13G | ADAR1 Capital Management, LLC | 8.8% | 59,000 | View |
| Aug 14, 2026 | SCHEDULE 13G | Daniel Schneeberger | 8.8% | 59,000 | View |
| Aug 14, 2026 | SCHEDULE 13G | venBio Global Strategic Fund V, L.P. | 9.99% | 279,340 | View |
| Aug 14, 2026 | SCHEDULE 13G | venBio Global Strategic GP V, LLC | 9.99% | 279,340 | View |
| Aug 13, 2026 | SCHEDULE 13G/A | Zhang Xiaofan | 0.6% | 162,452 | View |
| Aug 07, 2026 | SCHEDULE 13G/A | Logos Global Management LP | 10.7% | 286,308 | View |
| Aug 07, 2026 | SCHEDULE 13G/A | Logos Global Management GP LLC | 10.7% | 286,308 | View |
| Aug 07, 2026 | SCHEDULE 13G/A | Logos Global Master Fund LP | 6.6% | 176,678 | View |
| Aug 07, 2026 | SCHEDULE 13G/A | Logos GP LLC | 6.6% | 176,678 | View |
| Aug 07, 2026 | SCHEDULE 13G/A | Logos Opportunities Fund V LP | 4.1% | 109,630 | View |
| Aug 07, 2026 | SCHEDULE 13G/A | Logos Opportunities V GP LLC | 4.1% | 109,630 | View |
| Aug 07, 2026 | SCHEDULE 13G/A | Arsani William | 10.7% | 286,308 | View |
| Aug 07, 2026 | SCHEDULE 13G/A | Graham Walmsley | 4.1% | 109,630 | View |
| Aug 07, 2026 | SCHEDULE 13G | JANUS HENDERSON GROUP Ltd. | 9.99% | 266,712 | View |
| Aug 05, 2026 | SCHEDULE 13D | — | 9.99% | — | View |
| Aug 04, 2026 | SCHEDULE 13G | Logos Global Management LP | 9.9% | 276,704 | View |
| Aug 04, 2026 | SCHEDULE 13G | Logos Global Management GP LLC | 9.9% | 276,704 | View |
| Aug 04, 2026 | SCHEDULE 13G | Logos Global Master Fund LP | 9.9% | 120,026 | View |
| Aug 04, 2026 | SCHEDULE 13G | Logos GP LLC | 9.9% | 120,026 | View |
| Aug 04, 2026 | SCHEDULE 13G | Logos Opportunities Fund V LP | 9.9% | 256,704 | View |
| Aug 04, 2026 | SCHEDULE 13G | Logos Opportunities V GP LLC | 9.9% | 256,704 | View |
| Aug 04, 2026 | SCHEDULE 13G | Arsani William | 9.9% | 276,704 | View |
| Aug 04, 2026 | SCHEDULE 13G | Graham Walmsley | 9.9% | 256,704 | View |
| Aug 03, 2026 | SCHEDULE 13G | Perceptive Advisors LLC | 9.99% | 266,756 | View |
| Aug 03, 2026 | SCHEDULE 13G | Joseph Edelman | 9.99% | 266,756 | View |
| Aug 03, 2026 | SCHEDULE 13G | Perceptive Life Sciences Master Fund, Ltd. | 9.99% | 266,756 | View |
| Jul 30, 2026 | SCHEDULE 13G | RTW Fund Group GP, LLC | 9.99% | 266,307 | View |
| Jul 30, 2026 | SCHEDULE 13G | Roderick Wong | 9.99% | 266,307 | View |
| Jul 29, 2026 | SCHEDULE 13D/A | — | — | 22,331 | View |
| Jul 17, 2026 | SCHEDULE 13G/A | Zhang Xiaofan | — | — | View |
| Jul 14, 2026 | SCHEDULE 13G/A | Zhang Xiaofan | — | — | View |
| Jun 15, 2026 | SCHEDULE 13G | Zhang Xiaofan | 5.6% | 1,873,388 | View |
| May 15, 2026 | SCHEDULE 13G | Nantahala Capital Management, LLC | 6.0% | 2,000,000 | View |
| May 15, 2026 | SCHEDULE 13G | Wilmot B. Harkey | 6.0% | 2,000,000 | View |
| May 15, 2026 | SCHEDULE 13G | Daniel Mack | 6.0% | 2,000,000 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.